MiRus
PrivateLast Round
Corporate Funding
May 15, 2026
Est. Valuation
$4.44B
Total Funding Raised
$1.57B
Momentum
Quiet
No recent growth signals
Company Overview
MiRus is a medical technology company that develops and commercializes proprietary biomaterials, implants, and procedural solutions for the treatment of spinal, orthopedic, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MiRus Comps
Public and private peers based on sector, stage, and business model.
MiRus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 15, 2026 | ||||
| Series D | Jul 27, 2021 |
Key People
Founding team and executive leadership
MiRus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mammoth Scientific | Series C, Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Pivotal trial for TAVR system underway, targeting FDA/EMA submissions.
MiRus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MiRus's valuation, stock price, and market status.